SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Cedar Pollen Allergy - Pipeline Review, H2 2013 Research Report

[February 12, 2014]

Research and Markets: Cedar Pollen Allergy - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/x4w9s6/cedar_pollen) has announced the addition of the "Cedar Pollen Allergy - Pipeline Review, H2 2013" report to their offering.

'Cedar Pollen Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cedar Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cedar Pollen Allergy.

Scope

- A snapshot of the global therapeutic scenario for Cedar Pollen Allergy.

- A review of the Cedar Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of developent ranging from discovery till registration stages.


- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Cedar Pollen Allergy pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Cedar Pollen Allergy Overview

Therapeutics Development

Cedar Pollen Allergy - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Cedar Pollen Allergy - Therapeutics Assessment

Drug Profiles

TO-194SL - Drug Profile

TAC-201 - Drug Profile

Cry J1-galactomannan Conjugate - Drug Profile

JRC-LAMP Vax - Drug Profile

TO-206 - Drug Profile

Pollinex Quattro Japanese Cedar - Drug Profile

RGI-1001 - Drug Profile

Japanese Cedar Pollen Tablet - Drug Profile

Japanese Cedar Hypoallergenic Vaccine - Drug Profile

AllerJ - Drug Profile

Cedar Pollen Vaccine - Drug Profile

Vaccine For Japanese Cedar Pollen Allergy - Drug Profile

Featured News & Press Releases

Appendix

Companies Mentioned

Taiho Pharmaceutical Co., Ltd.

Allergy Therapeutics plc

Stallergenes S.A.

Torii Pharmaceutical Co., Ltd.

Anergis SA

REGiMMUNE Corporation

Immunomic Therapeutics, Inc.

Biomay AG

Adiga Life Sciences Inc.

For more information visit http://www.researchandmarkets.com/research/x4w9s6/cedar_pollen

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy